Decreased GLT-1 and increased SOD1 and HO-1 expression in astrocytes contribute to lumbar spinal cord vulnerability of SOD1-G93A transgenic mice

FEBS Letters

Volumn 584, Issue 8, 2010, Pages 1615-1622

  Guo, Yansu ^a,b   Duan, Weisong ^a,b   Li, Zhongyao ^a,b   Huang, Jing ^a,b   Yin, Yunxia ^a   Zhang, Kunxi ^a   Wang, Qian ^a   Zhang, Zhifang ^a   Li, Chunyan ^a,b  

^a HEBEI MEDICAL UNIVERSITY   (China)

^b Institute of Cardiocerebrovascular Disease   (China)

Author keywords

ALS; Astrocyte; Heme oxygenase 1; SOD1; Transgenic mice

Indexed keywords

COPPER ZINC SUPEROXIDE DISMUTASE; GLIAL GLUTAMATE TRANSPORTER 1; GLUTAMATE TRANSPORTER; HEME OXYGENASE 1; UNCLASSIFIED DRUG;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DOWN REGULATION; EXCITOTOXICITY; LUMBAR SPINAL CORD; MALE; MOTOR CORTEX; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSGENIC MOUSE;

ANIMALS; ASTROCYTES; CELL PROLIFERATION; CEREBRAL CORTEX; EXCITATORY AMINO ACID TRANSPORTER 2; FEMALE; GENE EXPRESSION REGULATION; HEME OXYGENASE-1; HUMANS; LUMBAR VERTEBRAE; MALE; MICE; MICE, TRANSGENIC; NERVE TISSUE PROTEINS; PROTEIN TRANSPORT; SPINAL CORD; SUPEROXIDE DISMUTASE; TIME FACTORS;

MUS MUSCULUS;

EID: 77951295221     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2010.03.025     Document Type: Article

References (30)

1. Rosen D.R., Siddique T., Patterson D., Figlewicz D.A., Sapp P., Hentati A., Donaldson D., Goto J., O'Regan J.P., Deng H.X., et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 1993, 362:59-62.
2. Gurney M.E., Pu H., Chiu A.Y., Dal Canto M.C., Polchow C.Y., Alexander D.D., Caliendo J., Hentati A., Kwon Y.W., Deng H.X., et al. Motor neuron degeneration in mice that express a human Cu, Zn superoxide dismutase mutation. Science 1994, 264:1772-1775.
3. Canton T., Pratt J., Stutzmann J.M., Imperato A., Boireau A. Glutamate uptake is decreased tardively in the spinal cord of FALS mice. Neuroreport 1998, 9:775-778.
4. Watanabe M., Dykes-Hoberg M., Culotta V.C., Price D.L., Wong P.C., Rothstein J.D. Histological evidence of protein aggregation in mutant SOD1 transgenic mice and in amyotrophic lateral sclerosis neural tissues. Neurobiol. Dis. 2001, 8:933-941.
5. Carrí M.T., Ferri A., Cozzolino M., Calabrese L., Rotilio G. Neurodegeneration in amyotrophic lateral sclerosis: the role of oxidative stress and altered homeostasis of metals. Brain Res. Bull. 2003, 61:365-374.
6. Rothstein J.D. Excitotoxicity and neurodegeneration in amyotrophic lateral sclerosis. Clin. Neurosci. 1995, 3:348-359.
7. Julien J.P. A role for neurofilaments in the pathogenesis of amyotrophic lateral sclerosis. Biochem. Cell Biol. 1995, 73:593-597.
8. Hall E.D., Oostveen J.A., Gurney M.E. Relationship of microglial and astrocytic activation to disease onset and progression in a transgenic model of familial ALS. Glia 1998, 23:249-256.
9. Bruijn L.I., Becher M.W., Lee M.K., Anderson K.L., Jenkins N.A., Copeland N.G., Sisodia S.S., Rothstein J.D., Borchelt D.R., Price D.L., Cleveland D.W. ALS-linked SOD1 mutant G85R mediates damage to astrocytes and promotes rapidly progressive disease with SOD1-containing inclusions. Neuron 1997, 18:327-338.
10. Howland D.S., Liu J., She Y., Goad B., Maragakis N.J., Kim B., Erickson J., Kulik J., DeVito L., Psaltis G., DeGennaro L.J., Cleveland D.W., Rothstein J.D. Focal loss of the glutamate transporter EAAT2 in a transgenic rat model of SOD1 mutant mediated amyotrophic lateral sclerosis (ALS). Proc. Natl. Acad. Sci. USA 2002, 99:1604-1609.
11. Bendotti C., Tortarolo M., Suchak S.K., Calvaresi N., Carvelli L., Bastone A., Rizzi M., Rattray M., Mennini T. Transgenic SOD1 G93A mice develop reduced GLT-1 in spinal cord without alterations in cerebrospinal fluid glutamate levels. J. Neurochem. 2001, 79:737-746.
12. Sasaki S., Warita H., Abe K., Komori T., Iwata M. EAAT1 and EAAT2 immunoreactivity in transgenic mice with a G93A mutant SOD1 gene. Neuroreport 2001, 12:1359-1362.
13. Weydt P., Hong S.Y., Kliot M., Moller T. Assessing disease onset and progression in the SOD1 mouse model of ALS. Neuroreport 2003, 14:1051-1054.
14. Nagai M., Re D.B., Nagata T., Chalazonitis A., Jessell T.M., Wichterle H., Przedborski S. Astrocytes expressing ALS-linked mutated SOD1 release factors selectively toxic to motor neurons. Nat. Neurosci. 2007, 10:615-622.
15. Yamanaka K., Chun S.J., Boillee S., Fujimori-Tonou N., Yamashita H., Gutmann D.H., Takahashi R., Misawa H., Cleveland D.W. Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis. Nat. Neurosci. 2008, 11:251-253.
16. Pekny M., Pekna M. Astrocyte intermediate filaments in CNS pathologies and regeneration. J. Pathol. 2004, 204:428-437.
17. Rothstein J.D., van Kammen M., Levy A.I., Martin L.J., Kuncl R.W. Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis. Ann. Neurol. 1995, 38:73-84.
18. Bristol L.A., Rothstein J.D. Glutamate transporter gene expression in amyotrophic lateral sclerosis motor cortex. Ann. Neurol. 1996, 39:676-679.
19. Vanoni C., Massari S., Losa M., Carrega P., Perego C., Conforti L., Pietrini G. Increased internalisation and degradation of GLT-1 glial glutamate transporter in a cell model for familial amyotrophic lateral sclerosis (ALS). J. Cell Sci. 2004, 117:5417-5426.
20. Choi A.M., Alam J. Heme oxygenase-1: function, regulation, and implication of a novel stress-inducible protein in oxidant-induced lung injury. Am. J. Respir. Cell Mol. Biol. 1996, 15:9-19.
21. Lee P.J., Alam J., Sylvester S.L., Inamdar N., Otterbein L., Choi A.M. Regulation of heme oxygenase-1 expression in vivo and in vitro in hyperoxic lung injury. Am. J. Respir. Cell Mol. Biol. 1996, 14:556-568.
22. Horikawa S., Yoneya R., Nagashima Y., Hagiwara K., Ozasa H. Prior induction of heme oxygenase-1 with glutathione depletor ameliorates the renal ischemia and reperfusion injury in the rat. FEBS Lett. 2002, 510:221-224.
23. Foresti R., Clark J.E., Green C.J., Motterlini R. Thiol compounds interact with nitric oxide in regulating heme oxygenase-1 induction in endothelial cells: involvement of superoxide and peroxynitrite anions. J. Biol. Chem. 1997, 272:18411-18417.
24. Gong P., Cederbaum A.I., Nieto N. Heme oxygenase-1 protects HepG2 cells against cytochrome P450 2E1-dependent toxicity. Free Radic. Biol. Med. 2004, 36:307-318.
25. Abraham N.G., Kushida T., McClung J., Weiss M., Quan S., Lafaro R., Darzynkiewicz Z., Wolin M. Heme oxygenase-1 attenuates glucose-mediated cell growth arrest and apoptosis in human microvessel endothelial cells. Circ. Res. 2003, 93:507-514.
26. Fujii H., Takahashi T., Nakahira K., Uehara K., Shimizu H., Matsumi M., Morita K., Hirakawa M., Akagi R., Sassa S. Protective role of heme oxygenase-1 in the intestinal tissue injury in an experimental model of sepsis. Crit. Care Med. 2003, 31:893-902.
27. Otterbein L., Sylvester S.L., Choi A.M. Hemoglobin provides protection against lethal endotoxemia in rats: the role of heme oxygenase-1. Am. J. Respir. Cell Mol. Biol. 1995, 13:595-601.
28. Vargas M.R., Pehar M., Cassina P., Martínez-Palma L., Thompson J.A., Beckman J.S., Barbeito L. Fibroblast growth factor-1 induces heme oxygenase-1 via nuclear factor erythroid 2-related factor 2 (Nrf2) in spinal cord astrocytes: consequences for motor neuron survival. J. Biol. Chem. 2005, 280:25571-25579.
29. Takeda A., Itoyama Y., Kimpara T., Zhu X., Avila J., Dwyer B.E., Perry G., Smith M.A. Heme catabolism and heme oxygenase in neurodegenerative disease. Antioxid. Redox Signal. 2004, 6:888-894.
30. Schipper H.M. Heme oxygenase expression in human central nervous system disorders. Free Radic. Biol. Med. 2004, 37:1995-2011.